Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Urotensin II (114-124), human acetate

Copy Product Info
🥰Excellent
Catalog No. TP1737L
Alias Urotensin II (114-124), human acetate(251293-28-4 free base)

Urotensin II (114-124), human acetate is an 11-amino acid residue peptide, is a potent vasoconstrictor and agonist for the orphan receptor GPR14.

Urotensin II (114-124), human acetate

Urotensin II (114-124), human acetate

Copy Product Info
🥰Excellent
Catalog No. TP1737LAlias Urotensin II (114-124), human acetate(251293-28-4 free base)
Urotensin II (114-124), human acetate is an 11-amino acid residue peptide, is a potent vasoconstrictor and agonist for the orphan receptor GPR14.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$196In StockIn Stock
5 mg$487In StockIn Stock
10 mg$696In StockIn Stock
25 mg$1,090In StockIn Stock
50 mg$1,490In StockIn Stock
100 mg$1,980In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:>99.99%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Urotensin II (114-124), human acetate is an 11-amino acid residue peptide, is a potent vasoconstrictor and agonist for the orphan receptor GPR14.
In vitro
Human Urotensin II (U-II) binds to recombinant human GPR14 with high affinity, and the binding is functionally coupled to calcium mobilization. Human Urotensin II induces concentration-dependent increases in intracellular calcium in a HEK-293 cell line expressing human GPR14 (EC50=0:62±0.17 nM, n=6)[1].
In vivo
Human Urotensin II (U-II) markedly increases total peripheral resistance in anaesthetized non-human primates, a response associated with profound cardiac contractile dysfunction[1].
SynonymsUrotensin II (114-124), human acetate(251293-28-4 free base)
Chemical Properties
Molecular Weight1448.63
FormulaC66H89N13O20S2
SmilesOC([C@H](C(C)C)NC([C@H]1NC([C@@H](NC([C@H](CCCCN)NC([C@@H](NC([C@@H](NC([C@H](CSSC1)NC([C@@H](NC([C@H]2N(CCC2)C([C@H]([C@H](O)C)NC([C@H](CCC(O)=O)N)=O)=O)=O)CC(O)=O)=O)=O)CC3=CC=CC=C3)=O)CC4=CNC5=C4C=CC=C5)=O)=O)CC6=CC=C(O)C=C6)=O)=O)=O.CC(O)=O
Relative Density.no data available
SequenceH-Glu-Thr-Pro-Asp-DL-Cys(1)-DL-Phe-Trp-DL-Lys-Tyr-DL-Cys(1)-Val-OH
Sequence ShortETPDCFWKYCV (Disulfide bridge: Cys5-Cys7)
Storage & Solubility Information
Storagekeep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 10 mM, Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM0.6903 mL3.4515 mL6.9031 mL34.5154 mL
5 mM0.1381 mL0.6903 mL1.3806 mL6.9031 mL
10 mM0.0690 mL0.3452 mL0.6903 mL3.4515 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Urotensin II (114-124), human acetate | purchase Urotensin II (114-124), human acetate | Urotensin II (114-124), human acetate cost | order Urotensin II (114-124), human acetate | Urotensin II (114-124), human acetate chemical structure | Urotensin II (114-124), human acetate in vivo | Urotensin II (114-124), human acetate in vitro | Urotensin II (114-124), human acetate formula | Urotensin II (114-124), human acetate molecular weight